首页 > 市场调查报告书 > 製药

疼痛

市场调查报告书

商品编码

1547755

全球疼痛管理治疗市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Pain Management Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球疼痛管理治疗市场需求预计将从 2023 年的 782.8 亿美元达到近 1,213.4 亿美元的市场规模，2024-2034 年研究期间复合年增长率为 4.99%。

疼痛管理疗法包括一系列旨在减轻或控制疼痛的药物、治疗和介入。该领域致力于解决急性和慢性疼痛问题。这些可能包括镇痛药物（鸦片类药物、非类固醇抗发炎药和抗忧郁药），以及物理治疗、针灸和神经阻断等非药物方法。目标是改善遭受疼痛的个人的生活品质和功能能力，同时最大限度地减少不良影响和依赖性的风险。

市场动态

疼痛管理治疗市场成长的主要原因是慢性疼痛和癌症相关疼痛的发生率不断上升。随着人口老化和生活方式的改变导致慢性疼痛疾病的发生率更高，因此需要有效的疼痛管理解决方案。此外，药物研究和开发的进步导致了疗效和安全性提高的创新疗法的推出，进一步推动了市场扩张。此外，医疗保健专业人员和患者现在更加意识到疼痛管理的重要性，而新型治疗方案的可用性正在促进市场成长。此外，疼痛管理疗法在骨科、神经病学和肿瘤学等各个医学专业中的广泛应用正在促进市场成长。

个人化医疗和精准医疗的趋势正在进一步推动针对满足每位患者特定需求的针对性疼痛管理疗法的开发，从而刺激市场创新。最后，旨在改善疼痛管理治疗机会的有利报销政策和措施正在促进市场成长，特别是在医疗基础设施不断发展的新兴经济体。然而，严格的监管批准和潜在的副作用可能会阻碍未来几年疼痛管理治疗市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球疼痛管理治疗市场的每个细分市场进行了包容性评估。疼痛管理治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

疼痛管理治疗市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按药物类别

非类固醇抗发炎药
麻醉剂
抗惊厥药
抗偏头痛药物
抗忧郁药
阿片类药物
非麻醉药品
止痛药

按指示

关节炎疼痛
神经性疼痛
癌症痛
慢性疼痛
术后疼痛
偏头痛
纤维肌痛
骨折
肌肉扭伤/拉伤
急性阑尾炎
其他

按疼痛类型

慢性的
急性

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲疼痛管理治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。疼痛管理治疗市场的主要参与者包括葛兰素史克公司、诺华公司、雅培实验室、礼来公司、Endo Health Solutions Inc.、辉瑞公司、普渡製药公司、默克公司、Mylan NV.、强生公司。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：疼痛管理治疗公司的竞争格局

疼痛管理治疗市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
GlaxoSmithKline Plc.

公司概况
公司收入
产品
最新动态

Novartis AG

公司概况
公司收入
产品
最新动态

Abbott Laboratories

公司概况
公司收入
产品
最新动态

Eli Lilly & Company

公司概况
公司收入
产品
最新动态

Endo Health Solutions Inc.

公司概况
公司收入
产品
最新动态

Pfizer Inc.

公司概况
公司收入
产品
最新动态

Purdue Pharma LP

公司概况
公司收入
产品
最新动态

Merck & Co. Inc.

公司概况
公司收入
产品
最新动态

Mylan NV.

公司概况
公司收入
产品
最新动态

Johnson & Johnson

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11213511

The global demand for Pain Management Therapeutics Market is presumed to reach the market size of nearly USD 121.34 Billion by 2032 from USD 78.28 Billion in 2023 with a CAGR of 4.99% under the study period 2024-2034.

Pain management therapeutics encompass a range of medications, treatments, and interventions aimed at alleviating or managing pain. This field addresses acute and chronic pain conditions. These may include analgesic medications (opioids, nonsteroidal anti-inflammatory drugs, and antidepressants), as well as non-pharmacological approaches like physical therapy, acupuncture, and nerve blocks. The goal is to improve quality of life and functional ability for individuals experiencing pain while minimizing the risks of adverse effects and dependency.

MARKET DYNAMICS

The primary reason behind the growth of the pain management therapeutics market is the rising incidence of chronic pain conditions and pain associated with cancer. With aging populations and lifestyle changes leading to higher incidences of chronic pain disorders, there is a demand for effective pain management solutions. Additionally, advancements in pharma research and development have led to the introduction of innovative therapeutics with improved efficacy and safety profiles, further driving market expansion. Moreover, the healthcare professionals and patients are now more aware regarding the importance of pain management and the availability of novel treatment options is fostering the market growth. Furthermore, the expanding application of pain management therapeutics across various medical specialties, including orthopedics, neurology, and oncology, is contributing to market growth.

The trend toward personalized medicine and precision healthcare is fueling a greater push for the development of targeted pain management therapies customized to meet the specific needs of each patient, thereby spurring innovation within the market. Lastly, favorable reimbursement policies and initiatives aimed at improving access to pain management treatments are facilitating market growth, particularly in emerging economies where healthcare infrastructure is evolving. However, stringent regulatory approvals and potential side effects may hinder the growth of the pain management therapeutics market in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Pain Management Therapeutics. The growth and trends of Pain Management Therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Pain Management Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

NSAIDS
Anesthetics
Anticonvulsant
Anti-Migraine Drugs
Antidepressant Drugs
Opioids
Non-Narcotics
Analgesics

By Indication

Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Pain
Post-Operative Pain
Migraine
Fibromyalgia
Bone Fracture
Muscle Sprain/Strain
Acute Appendicitis
Other

By Pain Type

Chronic
Acute

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pain Management Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pain Management Therapeutics market include GlaxoSmithKline Plc., Novartis AG, Abbott Laboratories, Eli Lilly & Company, Endo Health Solutions Inc., Pfizer Inc., Purdue Pharma L.P., Merck & Co. Inc., Mylan NV., Johnson & Johnson. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PAIN MANAGEMENT THERAPEUTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Class
- 3.7.2 Market Attractiveness Analysis By Indication
- 3.7.3 Market Attractiveness Analysis By Pain Type
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS

5.1. Overview By Drug Class
5.2. Historical and Forecast Data
5.3. Analysis By Drug Class
5.4. NSAIDS Historic and Forecast Sales By Regions
5.5. Anesthetics Historic and Forecast Sales By Regions
5.6. Anticonvulsant Historic and Forecast Sales By Regions
5.7. Anti-Migraine Drugs Historic and Forecast Sales By Regions
5.8. Antidepressant Drugs Historic and Forecast Sales By Regions
5.9. Opioids Historic and Forecast Sales By Regions
5.10. Non-Narcotics Historic and Forecast Sales By Regions
5.11. Analgesics Historic and Forecast Sales By Regions

6. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET ANALYSIS BY INDICATION

6.1. Overview By Indication
6.2. Historical and Forecast Data
6.3. Analysis By Indication
6.4. Arthritic Pain Historic and Forecast Sales By Regions
6.5. Neuropathic Pain Historic and Forecast Sales By Regions
6.6. Cancer Pain Historic and Forecast Sales By Regions
6.7. Chronic Pain Historic and Forecast Sales By Regions
6.8. Post-Operative Pain Historic and Forecast Sales By Regions
6.9. Migraine Historic and Forecast Sales By Regions
6.10. Fibromyalgia Historic and Forecast Sales By Regions
6.11. Bone Fracture Historic and Forecast Sales By Regions
6.12. Muscle Sprain/Strain Historic and Forecast Sales By Regions
6.13. Acute Appendicitis Historic and Forecast Sales By Regions
6.14. Other Historic and Forecast Sales By Regions

7. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET ANALYSIS BY PAIN TYPE

7.1. Overview By Pain Type
7.2. Historical and Forecast Data
7.3. Analysis By Pain Type
7.4. Chronic Historic and Forecast Sales By Regions
7.5. Acute Historic and Forecast Sales By Regions

8. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PAIN MANAGEMENT THERAPEUTICS COMPANIES

9.1. Pain Management Therapeutics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF PAIN MANAGEMENT THERAPEUTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. GlaxoSmithKline Plc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Novartis AG
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Abbott Laboratories
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Eli Lilly & Company
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Endo Health Solutions Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Pfizer Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Purdue Pharma L.P.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Merck & Co. Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Mylan NV.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Johnson & Johnson
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments